In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes
Authors:
- 1 April 2005
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 582 (1-2) , 35-41
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivoMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2003
- Genetic variability in susceptibility and response to toxicantsToxicology Letters, 2001
- Genetic variability in susceptibility and response to toxicantsToxicology Letters, 2001
- Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesomeCancer Chemotherapy and Pharmacology, 2000
- Supraadditive effect of 2 ′ ,2 ′ -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell linesCancer Chemotherapy and Pharmacology, 1999
- Gemcitabine: A pharmacologic and clinical overviewCancer Nursing, 1999
- Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasoneEuropean Journal of Pharmacology, 1999
- Cytogenetic consequences after occupational exposure to antineoplastic drugsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1998
- Characterisation of genotoxic properties of 2′,2′-difluorodeoxycytidineMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1997
- Combination therapy with gemcitabine in non-small cell lung cancerEuropean Journal of Cancer, 1997